PAR 0.00% 28.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm AGM Presentation, page-48

  1. 1,702 Posts.
    lightbulb Created with Sketch. 1853
    Just mulling this over further, I think what we need to see across the next...

    • 12 months: Is, a deal signed (MPS or Regional OA with up-front money), or else a new CR becomes more-or-less inevitable. Also TGA provisional application at least lodged, and awaiting approval.
    • 24 months: TGA provisional approval granted, providing the ability to sell Zilosul for OA for the first time (albiet Australia only). And/or another deal.

    Obviously all trials / recruitment need to be going well in the background too, plus (hopefully) exciting data from 008 can precede discussions around potential Accelerated Approval via the FDA too.

    However - as a minimum - to keep the company in cash while avoiding a CR (and assuming no major events e.g. a takeover), we're going to have to see the above bulleted points met imo.

    Can they achieve that? It would be amazing if they did. I have to say though, my gut feeling is that we'll need a future CR. Delighted to be wrong, and i'm a very bullish holder, but that's how I feel about it. I'm happy with what I hold, and if it takes off i'll have no regrets whatsoever - but with all of that in mind, I might keep some powder dry to add either on potential June selling, or in the back half of CY23 in case a deal hasn't arrived.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
0.000(0.00%)
Mkt cap ! $97.94M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 5719 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 1200 1
View Market Depth
Last trade - 10.04am 03/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.